Tianjin Lisheng Pharmaceutical Co Ltd (002393) — Cash Flow-to-Debt Ratio
Tianjin Lisheng Pharmaceutical Co Ltd (002393) has a Cash Flow-to-Debt Ratio of 0.32x as of December 2025, meaning its operating cash flow of CN¥287.81 Million could theoretically repay 0% of its total liabilities (CN¥890.89 Million) in one year. See Tianjin Lisheng Pharmaceutical Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Tianjin Lisheng Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2007–2025)
Historical debt coverage capacity for Tianjin Lisheng Pharmaceutical Co Ltd across 19 annual periods. Also explore Tianjin Lisheng Pharmaceutical Co Ltd (002393) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Tianjin Lisheng Pharmaceutical Co Ltd (2007–2025)
Year-by-year debt coverage analysis for Tianjin Lisheng Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see Tianjin Lisheng Pharmaceutical Co Ltd stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.51x | CN¥451.85 Million | CN¥890.89 Million | ▲ +466.3% |
| 2024 | 0.09x | CN¥88.26 Million | CN¥985.54 Million | ▼ -62.5% |
| 2023 | 0.24x | CN¥209.51 Million | CN¥877.17 Million | ▼ -32.1% |
| 2022 | 0.35x | CN¥331.38 Million | CN¥941.66 Million | ▲ +39.9% |
| 2021 | 0.25x | CN¥196.34 Million | CN¥780.42 Million | ▲ +137.2% |
| 2020 | 0.11x | CN¥76.37 Million | CN¥720.09 Million | ▼ -66.2% |
| 2019 | 0.31x | CN¥268.33 Million | CN¥855.85 Million | ▲ +35.8% |
| 2018 | 0.23x | CN¥162.69 Million | CN¥704.85 Million | ▼ -22.4% |
| 2017 | 0.30x | CN¥179.25 Million | CN¥602.32 Million | ▼ -19.3% |
| 2016 | 0.37x | CN¥173.60 Million | CN¥470.60 Million | ▼ -18.2% |
| 2015 | 0.45x | CN¥198.13 Million | CN¥439.50 Million | ▲ +110.9% |
| 2014 | 0.21x | CN¥72.24 Million | CN¥337.89 Million | ▼ -78.0% |
| 2013 | 0.97x | CN¥289.62 Million | CN¥298.20 Million | ▼ -42.6% |
| 2012 | 1.69x | CN¥250.72 Million | CN¥148.13 Million | ▼ -19.4% |
| 2011 | 2.10x | CN¥134.58 Million | CN¥64.07 Million | ▼ -13.2% |
| 2010 | 2.42x | CN¥186.55 Million | CN¥77.12 Million | ▲ +407.2% |
| 2009 | 0.48x | CN¥196.14 Million | CN¥411.26 Million | ▲ +1.9% |
| 2008 | 0.47x | CN¥126.59 Million | CN¥270.58 Million | ▲ +18.2% |
| 2007 | 0.40x | CN¥174.94 Million | CN¥441.87 Million | — |